Moderil is developed by Pfizer.

What development phase is Moderil in?

Moderil is FDA-approved (marketed).

What is the generic name of Moderil?

RESCINNAMINE is the generic (nonproprietary) name of Moderil.

Last reviewed 2026-04-20 · How we verify

Moderil (RESCINNAMINE)

Pfizer · FDA-approved approved Small molecule Quality 14/100

At a glance

Generic name	RESCINNAMINE
Sponsor	Pfizer
Drug class	rescinnamine
Target	Synaptic vesicular amine transporter
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved
First approval	1956

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Moderil CI brief — competitive landscape report
Moderil updates RSS · CI watch RSS
Pfizer portfolio CI